{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:10:38Z","timestamp":1791976238416,"version":"4.4.0"},"reference-count":280,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1994,4,1]],"date-time":"1994-04-01T00:00:00Z","timestamp":765158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[1994,4]]},"DOI":"10.1007\/bf00865490","type":"journal-article","created":{"date-parts":[[2004,12,27]],"date-time":"2004-12-27T14:32:11Z","timestamp":1104157931000},"page":"230-249","source":"Crossref","is-referenced-by-count":126,"title":["Lupus nephritis in childhood and adolescence"],"prefix":"10.1007","volume":"8","author":[{"given":"J. Stewart","family":"Cameron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","volume-title":"Dubois' systemic lupus erythematosus","author":"DJ Wallace","year":"1987","unstructured":"Wallace DJ, Dubois EL (1987) Dubois' systemic lupus erythematosus, 3rd edn. Lea and Febinger, Philadelphia","edition":"3rd edn."},{"key":"CR2","first-page":"59","volume":"22","author":"JS Cameron","year":"1993","unstructured":"Cameron JS (1993) Lupus and lupus nephritis in children. Adv Nephrol 22:59?119","journal-title":"Adv Nephrol"},{"key":"CR3","first-page":"1407","volume-title":"Pediatric kidney disease","author":"JS Cameron","year":"1992","unstructured":"Cameron JS (1992) Lupus nephritis. In: Edelmann CE, Spitzer A, Travis LB, Meadow SR (eds) Pediatric kidney disease, 2nd edn. Little Brown, Boston pp 1407?1465","edition":"2nd edn."},{"key":"CR4","volume-title":"The mosaic of autoimmunity","author":"Y Schoenfeld","year":"1989","unstructured":"Schoenfeld Y, Isenberg D (1989) The mosaic of autoimmunity. Elsevier, Amsterdam"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00005792-197607000-00003","volume":"55","author":"FC Arnett","year":"1976","unstructured":"Arnett FC, Schulman LE (1976) Studies in familial systemic lupus erythematosus. Medicine (Baltimore) 55:313?322","journal-title":"Medicine (Baltimore)"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1542\/peds.83.2.235","volume":"83","author":"TJA Lehman","year":"1989","unstructured":"Lehman TJA, McCurdy DK, Bernstein BH, King KK, Hanson V (1989) Systemic lupus erythematosus in the first decade of life. Pediatrics 83:235?239","journal-title":"Pediatrics"},{"key":"CR7","first-page":"2022","volume":"18","author":"M L\u00e9vy","year":"1989","unstructured":"L\u00e9vy M, Montes de Oca M, Babron MC (1989) Incidence du lupus \u00e9rythemateux diss\u00e9min\u00e9 de l'enfant en r\u00e9gion parisienne. Presse M\u00e9d 18:2022","journal-title":"Presse M\u00e9d"},{"key":"CR8","first-page":"52","volume-title":"Lupus \u00e9rythemateux diss\u00e9min\u00e9 chez l'enfant. \u00c9tude collaborative en r\u00e9gion parisienne. Journ\u00e9es Parisiennes de P\u00e9diatrie","author":"M L\u00e9vy","year":"1989","unstructured":"L\u00e9vy M, Montes de Oca M, Babron MC (1989) Lupus \u00e9rythemateux diss\u00e9min\u00e9 chez l'enfant. \u00c9tude collaborative en r\u00e9gion parisienne. Journ\u00e9es Parisiennes de P\u00e9diatrie. Flammarion, Paris, pp 52?58"},{"issue":"Suppl 6A","key":"CR9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/0002-9343(88)90382-8","volume":"85","author":"Z Fronek","year":"1988","unstructured":"Fronek Z, Timmerman LA, Alper CA, Hahn BV, Kalunian K, Peterlin BM, McDevitt HD (1988) Major histocompatibility complex associations with systemic lupus erythematosus. Am J Med 85 [Suppl 6A]:42?44","journal-title":"Am J Med"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/anr.1780321009","volume":"32","author":"JD Reveille","year":"1989","unstructured":"Reveille JD, Schrohenloher RE, Acton RT, Barger BO (1989) DNA analysis of HLA-DR and DQ genes in American blacks with systemic lupus erythematosus. Arthritis Rheum 32:1243?1251","journal-title":"Arthritis Rheum"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/art.1780220403","volume":"22","author":"MK Serdula","year":"1979","unstructured":"Serdula MK, Rhoads GG (1979) Frequency of systemic lupus erythematosus in different ethnic groups in Hawaii. Arthritis Rheum 22:328?333","journal-title":"Arthritis Rheum"},{"key":"CR12","first-page":"481","volume":"137","author":"A Tejani","year":"1983","unstructured":"Tejani A, Nicastri AD, Chen C-K, Fikrig S, Gurumurthy K (1983) Lupus nephritis in black and hispanic children. Am J Dis Child 137:481?483","journal-title":"Am J Dis Child"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-197801000-00001","volume":"57","author":"V Agnello","year":"1978","unstructured":"Agnello V (1978) Complement deficiency states. Medicine (Baltimore) 57:1?23","journal-title":"Medicine (Baltimore)"},{"key":"CR14","first-page":"328","volume":"31","author":"JL Roberts","year":"1978","unstructured":"Roberts JL, Schwartz MM, Lewis EJ (1978) Hereditary C2 deficiency and systemic lupus erythematosus associated with severe glomerulonephritis. Clin Exp Immunol 31:328?338","journal-title":"Clin Exp Immunol"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF00857655","volume":"4","author":"S Clemenceau","year":"1990","unstructured":"Clemenceau S, Castellano F, Oca MM de, Kaplan C, Danon F, Levy M (1990) C4 null alleles in childhood onset systemic lupus erythematosus. Is there any relationship with renal disease? Pediatr Nephrol 4:207?212","journal-title":"Pediatr Nephrol"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/bmj.286.6363.425","volume":"286","author":"AHL Fielder","year":"1983","unstructured":"Fielder AHL, Walport MJ, Batchelor JR, Rynes RI, Black CM, Dodi IA, Hughes GRV (1983) Family studies of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility. BMJ 286:425?428","journal-title":"BMJ"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/art.1780271201","volume":"27","author":"JG Wilson","year":"1984","unstructured":"Wilson JG, Fearon DT (1984) Altered expression of complement receptors as a pathogenetic factor in systemic lupus erythematosus. Arthritis Rheum 27:1321?1328","journal-title":"Arthritis Rheum"},{"key":"CR18","first-page":"501","volume":"69","author":"M Walport","year":"1987","unstructured":"Walport M, Ng YC, Lachmann PJ (1987) Erythrocytes transfused into patients with SLE and haemolytic anaemia lose complement receptor type 1 from their cell surface. Clin Exp Immunol 69: 501?507","journal-title":"Clin Exp Immunol"},{"key":"CR19","first-page":"13","volume":"10","author":"V Yewdall","year":"1983","unstructured":"Yewdall V, Cameron JS, Nathan AW, Neild G, Ogg CS, Williams DG (1983) Systemic lupus erythematosus and IgA deficiency. J Clin Lab Immunol 10:13?18","journal-title":"J Clin Lab Immunol"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1056\/NEJM198101223040401","volume":"304","author":"TJ Lawley","year":"1981","unstructured":"Lawley TJ, Hall RP, Fauci AS, Katz SI, Hamberger MI, Frank MM (1981) Defective Fc receptor functions associated with the haplotype HLA-A1-B8-DRw3 haplotype. N Engl J Med 304: 185?192","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"CR21","first-page":"126","volume":"2","author":"WG Couser","year":"1982","unstructured":"Couser WG, Salant DJ, Madaio MP, Adler S, Groggel GC (1982) Factors influencing glomerular and tubulointerstitial patterns of injury in SLE. Am J Kidney Dis 2 [Suppl 1]:126?134","journal-title":"Am J Kidney Dis"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/ki.1990.14","volume":"37","author":"E Alexopoulos","year":"1990","unstructured":"Alexopoulos E, Cameron JS, Hartley BH (1990) Lupus nephritis: correlation of interstitial cells with glomerular function. Kidney Int 37:100?109","journal-title":"Kidney Int"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/ki.1975.47","volume":"7","author":"JR Brentjens","year":"1975","unstructured":"Brentjens JR, Sepulveda M, Baliah T, Benzel C, Erlanger BF, Elwood C, Montes M, Hsu KC, Andres GA (1975) Interstitital immune complex nephritis in patients with systemic lupus erythematosus. Kidney Int 7:342?350","journal-title":"Kidney Int"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/ki.1986.223","volume":"30","author":"VD D'Agati","year":"1986","unstructured":"D'Agati VD, Appel GB, Estes D, Knowles DM II, Pirani CL (1986) Monoclonal antibody identification of infiltrating mononuclear leukocytes in lupus nephritis. Kidney Int 30:573?581","journal-title":"Kidney Int"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/BF00878382","volume":"6","author":"JS Cameron","year":"1992","unstructured":"Cameron JS (1992) Tubular and interstitial factors in the progression of glomerulonephritis. Pediatr Nephrol 6:292?303","journal-title":"Pediatr Nephrol"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0002-9343(79)90789-7","volume":"67","author":"CR Steinman","year":"1979","unstructured":"Steinman CR (1979) Circulating DNA in systemic lupus erythematosus. Am J Med 67:429?435","journal-title":"Am J Med"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1172\/JCI114716","volume":"86","author":"PM Rumore","year":"1990","unstructured":"Rumore PM, Steinman CR (1990) Endogenous circulating DNA in systemic lupus erythematosus. Occurrence as multimeric complexes bound to histone. J Clin Invest 86:69?74","journal-title":"J Clin Invest"},{"key":"CR28","first-page":"605","volume":"43","author":"D Adu","year":"1981","unstructured":"Adu D, Dobson J, Williams DG (1981) DNA-anti-DNA circulating complexes in the nephritis of systemic lupus erythematosus. Clin Exp Immunol 43:605?614","journal-title":"Clin Exp Immunol"},{"key":"CR29","first-page":"109","volume":"74","author":"D Koffler","year":"1974","unstructured":"Koffler D, Agnello V, Kunkel HG (1974) Polynucleotide immune complexes in the serum and glomeruli of patients with systemic lupus erythematosus. Am J Pathol 74:109?122","journal-title":"Am J Pathol"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/ki.1991.91","volume":"39","author":"T Sasaki","year":"1991","unstructured":"Sasaki T, Hatekayama A, Shibata S, Osaki H, Suzuki M, Horie K, Kitagama Y, Yoshinaga K (1991) Heterogeneity of immune complex derived anti-DNA antibodies associated with lupus nephritis. Kidney Int 39:746?753","journal-title":"Kidney Int"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/ki.1992.428","volume":"42","author":"R-M Termaat","year":"1992","unstructured":"Termaat R-M, Assmann KJM, Dijkman H, Gompel F van, Smeenk RJT, Berden JHM (1992) Anti-DNA antibodies can bind to the glomerulus via two distinct mechanisms. Kidney Int 42: 1363?1371","journal-title":"Kidney Int"},{"key":"CR32","first-page":"389","volume":"54","author":"HA Lake","year":"1985","unstructured":"Lake HA, Morgan A, Henderson B, Staines NA (1985) A key role for fibronectin in the sequential binding of native dsDNA and monoclonal anti-DNA antibodies to components of the extracellular matrix: its possible significance in glomerulonephritis Immunology 54:389?395","journal-title":"Immunology"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.4049\/jimmunol.142.9.3076","volume":"142","author":"E Raz","year":"1989","unstructured":"Raz E, Brezis M, Rosenmann E, Eilat D (1989) Anti-DNA antibodies bind directly to renal antigens and induced kidney dysfunction in the isolated perfused rat kidney. J Immunol 142: 3076?3082","journal-title":"J Immunol"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0896-8411(91)90159-A","volume":"4","author":"G Frampton","year":"1991","unstructured":"Frampton G, Hobby P, Morgan A, Staines NA, Cameron JS (1991) A role for DNA in anti-DNA antibodies binding to endothelial cells. J Autoimmunity 4:463?478","journal-title":"J Autoimmunity"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1365-2249.1992.tb03041.x","volume":"88","author":"TM Chan","year":"1992","unstructured":"Chan TM, Frampton G, Staines NA, Hobby P, Perry GJ, Cameron JS (1992) Different mechanisms by which monoclonal anti-DNA antibodies bind to human endothelial cells and glomerular mesangial cells. Clin Exp Immunol 88:68?74","journal-title":"Clin Exp Immunol"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1084\/jem.169.6.1879","volume":"169","author":"TMJ Schmiedke","year":"1989","unstructured":"Schmiedke TMJ, Stockl FW, Weber R, Sugisaki Y, Batsford SR, Vogt A (1989) Histones have high affinity for the glomerular basement membrane. Relevance for immune complex formation in lupus nephritis. J Exp Med 169:1879?1894","journal-title":"J Exp Med"},{"key":"CR37","first-page":"1276","volume":"25","author":"EM Tan","year":"1982","unstructured":"Tan EM, Cohen AS, Fries JF, Masi AT, MsShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1992 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1276?1277","journal-title":"Arthritis Rheum"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0022-3476(82)80203-5","volume":"101","author":"KS Barron","year":"1982","unstructured":"Barron KS, Person DA, Brewer EJ, Beale MG, Robson AM (1982) Pulse methylprednisolone therapy in diffuse proliferative lupus nephritis. J Pediatr 101:137?141","journal-title":"J Pediatr"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/ard.40.4.325","volume":"40","author":"F Caiero","year":"1981","unstructured":"Caiero F, Michielson MG, Bernstein R, Hughes GRV, Ansell B (1981) Systemic lupus erythematosus in childhood. Ann Rheum Dis 40:325?331","journal-title":"Ann Rheum Dis"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1001\/archinte.1964.00280080036008","volume":"113","author":"RE Kellum","year":"1964","unstructured":"Kellum RE, Haserick JK (1964) Systemic lupus erythematosus: a statistical evaluation of mortality based on a consecutive series of 299 patients. Arch Intern Med 113:200?207","journal-title":"Arch Intern Med"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1542\/peds.26.4.570","volume":"26","author":"D Cook","year":"1961","unstructured":"Cook D, Wedgwood RJP, Craig JM, Hartmann JR, Janeway CA (1961) Systemic lupus erythematosus. Pediatrics 26:570?585","journal-title":"Pediatrics"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0002-9343(77)90355-2","volume":"62","author":"AJ Fish","year":"1977","unstructured":"Fish AJ, Blau EB, Westberg NG, Burke BA, Vernier RL, Michael AF (1977) Systemic lupus erythematosus within the first two decades of life. Am J Med 62:99?117","journal-title":"Am J Med"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0022-3476(76)80529-X","volume":"89","author":"EH Garin","year":"1976","unstructured":"Garin EH, Donnely WH, Fennell RS, Richard GA (1976) Nephritis of systemic lupus erythematosus in children. J Pediatr 89: 366?371","journal-title":"J Pediatr"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/0090-1229(83)90024-7","volume":"29","author":"RS Glidden","year":"1983","unstructured":"Glidden RS, Manzouranis C, Borel Y (1983) Systemic lupus erythematosus in childhood: clinical manifestations and improved survival in fifty-five patients. Clin Immunol Immunopathol 29: 196?210","journal-title":"Clin Immunol Immunopathol"},{"key":"CR45","first-page":"289","volume":"26","author":"D Gribetz","year":"1959","unstructured":"Gribetz D, Henley WL (1959) Systemic lupus erythematosus in childhood. J Mount Sinai Hosp 26:289?296","journal-title":"J Mount Sinai Hosp"},{"key":"CR46","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1542\/peds.40.5.822","volume":"40","author":"WW Hagge","year":"1967","unstructured":"Hagge WW, Burke EC, Stickler GB (1967) Treatment of systemic lupus erythematosus complicated by nephritis in children. Pediatrics 40:822?827","journal-title":"Pediatrics"},{"key":"CR47","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1542\/peds.32.2.257","volume":"32","author":"JC Jacobs","year":"1963","unstructured":"Jacobs JC (1963) Systemic lupus erythematosus in childhood. Pediatrics 32:257?264","journal-title":"Pediatrics"},{"issue":"Suppl","key":"CR48","first-page":"287","volume":"20","author":"KK King","year":"1977","unstructured":"King KK, Kornreich HK, Bernstein BH, Singsen BH, Hanson V (1977) The clinical spectrum of systemic lupus erythematosus in childhood. Arthritis Rheum 20 [Suppl]:287?293","journal-title":"Arthritis Rheum"},{"key":"CR49","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1542\/peds.42.1.37","volume":"42","author":"AG Meislin","year":"1968","unstructured":"Meislin AG, Rothfield N (1968) Systemic lupus erythematosus in childhood. Analysis of 42 cases, with comparative data on 200 adult cases followed concurrently. Pediatrics 42:37?49","journal-title":"Pediatrics"},{"key":"CR50","first-page":"351","volume-title":"N\u00e9phrologie p\u00e9diatrique","author":"P Niaudet","year":"1983","unstructured":"Niaudet P, L\u00e9vy M (1983) Lupus \u00e9rythemateux diss\u00e9min\u00e9. In: Royer P, Habib R, Mathieu H, Broyer M (eds) N\u00e9phrologie p\u00e9diatrique. Flammarion. Paris, pp 351?367"},{"key":"CR51","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1177\/000992287701600906","volume":"16","author":"DG Norris","year":"1977","unstructured":"Norris DG, Colon AR, Stickler GB (1977) Systemic lupus erythematosus in children. The complex problems of diagnosis and treatment encountered in 101 such patients at the Mayo clinic. Clin Pediatr (Phila) 16:774?778","journal-title":"Clin Pediatr (Phila)"},{"key":"CR52","first-page":"147","volume":"23","author":"KI Okawa","year":"1976","unstructured":"Okawa KI, Wada H, Kobayashi O (1976) Systemic lupus erythematosus in children. Acta Med Biol 23:147?170","journal-title":"Acta Med Biol"},{"key":"CR53","first-page":"942","volume":"10","author":"RDA Peterson","year":"1963","unstructured":"Peterson RDA, Vernier RL, Good RA (1963) Lupus erythematosus. Pediatr Clin North Am 10:942?978","journal-title":"Pediatr Clin North Am"},{"issue":"Suppl 1","key":"CR54","first-page":"212","volume":"2","author":"JL Platt","year":"1982","unstructured":"Platt JL, Burke BA, Fish AJ, Kim Y, Michael AF (1982) Systemic lupus erythematosus in the first two decades of life. Am J Kidney Dis 2 [Suppl 1]:212?221","journal-title":"Am J Kidney Dis"},{"key":"CR55","first-page":"36","volume":"3","author":"MJ Robinson","year":"1967","unstructured":"Robinson MJ, Williams AL (1967) Systemic lupus erythematosus in childhood. Aust Pediatr J 3:36?47","journal-title":"Aust Pediatr J"},{"key":"CR56","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0307-742X(21)00209-5","volume":"8","author":"J Schaller","year":"1982","unstructured":"Schaller J (1982) Lupus in childhood. Clin Rheum Dis 8:219?228","journal-title":"Clin Rheum Dis"},{"key":"CR57","first-page":"599","volume":"21","author":"C Wallace","year":"1978","unstructured":"Wallace C, Schaller JG, Emery H, Wedgwood R (1978) Prospective study of childhood systemic lupus erythematosus (SLE). Arthritis Rheum 21:599?600","journal-title":"Arthritis Rheum"},{"key":"CR58","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jama.1981.03310340024021","volume":"245","author":"DJ Wallace","year":"1981","unstructured":"Wallace DJ, Podell T, Weiner J, Klinenberg JR, Forouzesh S, Dubois EL (1981) Systemic lupus erythematosus-survival patterns. Experience with 609 patients. JAMA 245:934?938","journal-title":"JAMA"},{"key":"CR59","first-page":"929","volume":"130","author":"PA Walravens","year":"1976","unstructured":"Walravens PA, Chase HP (1976) The prognosis of childhood systemic lupus erythematosus. Am J Dis Child 130:929?933","journal-title":"Am J Dis Child"},{"key":"CR60","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1651-2227.1956.tb17690.x","volume":"45","author":"B Zetterstrom","year":"1956","unstructured":"Zetterstrom B, Berglund G (1956) Systemic lupus erythematosus in childhood. A clinical study. Acta Paediatr Scand 45:189?204","journal-title":"Acta Paediatr Scand"},{"key":"CR61","first-page":"230","volume-title":"Pediatric nephrology","author":"JS Cameron","year":"1984","unstructured":"Cameron JS, Chantler C, Haycock G, Hicks J (1984) The nephritis of systemic lupus erythematosus in childhood and adolescence. In Brodehl J, Ehrich JWW (eds) Pediatric nephrology. Springer, New York Berlin Heidelberg, pp 230?236"},{"key":"CR62","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1136\/adc.56.10.779","volume":"56","author":"MC Morris","year":"1981","unstructured":"Morris MC, Cameron JS, Chantler C, Turner DR (1981) Systemic lupus erythematosus with nephritis. Arch Dis Child 56:779?783","journal-title":"Arch Dis Child"},{"key":"CR63","first-page":"123","volume":"129","author":"J Grossman","year":"1975","unstructured":"Grossman J, Schwartz RH, Callerame ML, Condemi JI (1975) Systemic lupus erythematosus in a one year old child. Am J Dis Child 129:123?125","journal-title":"Am J Dis Child"},{"key":"CR64","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/000331976902000505","volume":"20","author":"KB Desser","year":"1969","unstructured":"Desser KB, Sartiano GP, Cooper JL (1969) Lupus livedo and cutaneous infarction. Angiology 20:261","journal-title":"Angiology"},{"key":"CR65","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0307-742X(21)00010-2","volume":"1","author":"EGL Bywaters","year":"1975","unstructured":"Bywaters EGL (1975) Jaccoud's syndrome. A sequel to the joint involvement of systemic lupus erythematosus. Clin Rheum Dis 1: 125?148","journal-title":"Clin Rheum Dis"},{"key":"CR66","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1056\/NEJM198809293191302","volume":"319","author":"E Galve","year":"1988","unstructured":"Galve E, Candell-Riera J, Pigrau C, Permaeyer-Miralda G, Garciadel Castillo H, Soler-Soler J (1988) Prevalence, morphologic types and evolution of cardiac valvular disease in systemic lupus erythematosus. N Engl J Med 319:817?823","journal-title":"N Engl J Med"},{"key":"CR67","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0002-9343(90)90368-N","volume":"89","author":"W-H Leung","year":"1990","unstructured":"Leung W-H, Wing K-L, Lau C-P, Wong C-K, Liu H-W (1990) Association between antiphospholipid antibodies and cardiac abnormalities in patients with systemic lupus erythematosus. Am J Med 89:411?419","journal-title":"Am J Med"},{"key":"CR68","doi-asserted-by":"crossref","unstructured":"Case records of the Massachusetts General Hospital (1988) Case no 37-1988. N Engl J Med 319: 699?712","DOI":"10.1056\/NEJM198809153191107"},{"key":"CR69","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/art.1780270509","volume":"27","author":"G Mintz","year":"1984","unstructured":"Mintz G, Acevedo-Vasquez E, Guterriez-Espinosa G, Avelar-Garnica F (1984) Renal vein thrombosis and inferior vena cava thrombosis in systemic lupus erythematosus. Arthritis Rheum 27: 539?544","journal-title":"Arthritis Rheum"},{"key":"CR70","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0022-3476(86)80839-3","volume":"108","author":"RW Miller","year":"1986","unstructured":"Miller RW, Salcedo JR, Fink RJ, Murphy TM, Magilavy DB (1986) Pulmonary hemorrhage in pediatric patients with systemic lupus erythematosus. J Pediatr 108:576?579","journal-title":"J Pediatr"},{"key":"CR71","doi-asserted-by":"crossref","first-page":"941","DOI":"10.7326\/0003-4819-114-11-941","volume":"114","author":"SB Abramson","year":"1991","unstructured":"Abramson SB, Dobro J, Eberle M, Benton M, Reibman J, Epstein H, Rapoport DM, Belmont M, Goldring RM (1991) Acute reversible hypoxemia in systemic lupus erythematosus. Ann Intern Med 114:941?947","journal-title":"Ann Intern Med"},{"key":"CR72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00290244","volume":"11","author":"AP Dam Van","year":"1991","unstructured":"Van Dam AP (1991) Diagnosis and pathogenesis of CNS lupus. Rheumatol Int 11:1?11","journal-title":"Rheumatol Int"},{"key":"CR73","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1002\/art.1780241109","volume":"24","author":"CL Yancey","year":"1981","unstructured":"Yancey CL, Doughty RA, Arthreya BH (1981) Central nervous system involvement in childhood systemic lupus erythematosus. Arthritis Rheum 24:1389?1395","journal-title":"Arthritis Rheum"},{"key":"CR74","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1136\/adc.63.8.968","volume":"63","author":"J King","year":"1988","unstructured":"King J, Aukett A, Smith MF, Hosking G, Milford Ward A, Hughes P (1988) Cerebral systemic lupus erythematosus. Arch Dis Child 63:968?970","journal-title":"Arch Dis Child"},{"key":"CR75","first-page":"27","volume":"66","author":"L Lim","year":"1988","unstructured":"Lim L, Ron MA, Ormerod IEC, Miller DH, Logsdail SJ, Walport MJ, Harding AE (1988) Psychiatric and neurological manifestations in systemic lupus erythematosus. Q J Med 66:27?38","journal-title":"Q J Med"},{"key":"CR76","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0140-6736(78)90680-3","volume":"I","author":"AJ Pinching","year":"1978","unstructured":"Pinching AJ, Travers RL, Hughes GRV, Jones T, Moss S (1978) Oxygen-15 brain scanning for detection of cerebral involvement. Lancet I:898?900","journal-title":"Lancet"},{"key":"CR77","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1542\/peds.61.2.308","volume":"61","author":"JK Herd","year":"1978","unstructured":"Herd JK, Mehdi M, Uzendoski DM, Saldivar VA (1978) Chorea associated with systemic lupus erythematosus: report of 2 cases and review of the literature. Pediatrics 61:308?313","journal-title":"Pediatrics"},{"key":"CR78","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1136\/adc.53.4.345","volume":"53","author":"LF Kukla","year":"1978","unstructured":"Kukla LF, Reddy C, Silkalns G, Prasad M (1978) Systemic lupus erythematosus presenting as chorea. Arch Dis Child 53:345?347","journal-title":"Arch Dis Child"},{"key":"CR79","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/ard.47.8.681","volume":"47","author":"MA Khamashta","year":"1988","unstructured":"Khamashta MA, Gil A, Anciones B, Lavilla P, Valencia ME, Pintado V, Vasquez JJ (1988) Chorea in systemic lupus erythematosus: association with antiphospholipid antibodies. Ann Rheum Dis 47:681?683","journal-title":"Ann Rheum Dis"},{"key":"CR80","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/0887-8994(90)90061-5","volume":"6","author":"GN McAbee","year":"1990","unstructured":"McAbee GN, Barasch ES (1990) Resolving MRI lesions in lupus erythematosus selectively involving the brainstem. Pediatr Neurol 6:186?189","journal-title":"Pediatr Neurol"},{"key":"CR81","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1136\/ard.39.1.50","volume":"39","author":"GJ Becker","year":"1980","unstructured":"Becker GJ, Waldburger M, Hughes GRV, Pepys M (1980) Value of serum C-reactive protein measurement in the investigation of fever in systemic lupus erythematosus. Ann Rheum Dis 39:50?52","journal-title":"Ann Rheum Dis"},{"key":"CR82","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/art.1780200505","volume":"20","author":"S Honig","year":"1977","unstructured":"Honig S, Gorevic P, Weissmann G (1977) C-reactive protein in systemic lupus erythematosus. Athritis Rheum 20:1065?1070","journal-title":"Athritis Rheum"},{"key":"CR83","first-page":"245","volume":"7","author":"RL Nadorra","year":"1987","unstructured":"Nadorra RL, Nakazato Y, Landing BH (1987) Pathologic features of gastrointestinal tract lesions in childhood onset systemic lupus erythematosus: study of 26 patients with review of the literature. Pediatr Pathol 7:245?259","journal-title":"Pediatr Pathol"},{"key":"CR84","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0002-9343(80)90378-2","volume":"69","author":"BA Runyon","year":"1980","unstructured":"Runyon BA, La Breque DR, Anuras S (1980) The spectrum of liver disease in systemic lupus erythematosus. Report of 33 histologically-proved cases and review of the literature. Am J Med 69:187?194","journal-title":"Am J Med"},{"key":"CR85","first-page":"401","volume":"53","author":"MH Miller","year":"1984","unstructured":"Miller MH, Urowitz MB, Gladman DD, Blendis LM (1984) The liver in systemic lupus erythematosus. Q J Med 53:401?409","journal-title":"Q J Med"},{"key":"CR86","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0002-9343(88)80096-2","volume":"85","author":"TJ Laing","year":"1988","unstructured":"Laing TJ (1988) Gastrointestinal vasculitis and pneumatosis intestinalis due to systemic lupus erythematosus: successful treatment with pulse intravenous cyclophosphamide. Am J Med 85: 555?558","journal-title":"Am J Med"},{"key":"CR87","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/0002-9343(64)90087-7","volume":"36","author":"MA Shearn","year":"1965","unstructured":"Shearn MA (1965) Normocholesterolemic nephrotic syndrome of systemic lupus erythematosus. Am J Med 36:250?261","journal-title":"Am J Med"},{"key":"CR88","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/ki.1989.189","volume":"36","author":"GC Groggel","year":"1989","unstructured":"Groggel GC, Cheung AK, Ellis-Benigni K, Wilson DE (1989) Treatment of nephrotic hyperlipoproteinemia with gemfibrozil. Kidney Int 36:266?271","journal-title":"Kidney Int"},{"key":"CR89","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0022-3476(84)80353-4","volume":"105","author":"K Phadke","year":"1984","unstructured":"Phadke K, Trachtman H, Nicastri A, Chen CK, Tejani A (1984) Acute renal failure as the initial manifestation of systemic lupus erythematosus in children. J Pediatr 105:38?41","journal-title":"J Pediatr"},{"key":"CR90","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1001\/archpedi.1978.02120280047010","volume":"132","author":"A Fraga","year":"1978","unstructured":"Fraga A, Gudino J, Ramon-Niembro F, Alarcon-Segovia D (1978) Mixed connective tissue disease in childhood. Am J Dis Child 132:263?265","journal-title":"Am J Dis Child"},{"key":"CR91","first-page":"228","volume-title":"Platelets in health and disease","author":"JS Cameron","year":"1991","unstructured":"Cameron JS (1991) The platelet in renal disease. In: Page CF (ed) Platelets in health and disease. Blackwell, Oxford, pp 228?260"},{"key":"CR92","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1007\/BF00858646","volume":"4","author":"JS Cameron","year":"1990","unstructured":"Cameron JS, Frampton G (1990) The ?antiphospholipid syndrome? and the ?lupus anticoagulant?. Pediatr Nephrol 4: 662?678","journal-title":"Pediatr Nephrol"},{"key":"CR93","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/ki.1991.155","volume":"39","author":"G Frampton","year":"1991","unstructured":"Frampton G, Hicks J, Cameron JS (1991) Significance of antiphospholipid antibodies in patients with lupus nephritis. Kidney Int 39:1225?1331","journal-title":"Kidney Int"},{"key":"CR94","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/adc.66.6.713","volume":"66","author":"MA Montes de Oca","year":"1991","unstructured":"Montes de Oca MA, Babron MC, Bletry O, Broyer M, Courtecuisse V, Fontaine JL, Loirat C, Mery J-P, Reinert P, Wechsler B, Levy M (1991) Thrombosis in systemic lupus erythematosus: a French collaborative study. Arch Dis Child 66:713?717","journal-title":"Arch Dis Child"},{"key":"CR95","first-page":"1389","volume":"15","author":"WJ Shergy","year":"1988","unstructured":"Shergy WJ, Kredich DW, Pisetsky DS (1988) The relationship of anticardiolipin antibody to disease manifestations in pediatric systemic lupus erythematosus. J Rheumatol 15:1389?1394","journal-title":"J Rheumatol"},{"key":"CR96","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00005792-198911000-00003","volume":"68","author":"D Alarcon-Segovia","year":"1990","unstructured":"Alarcon-Segovia D, Deleze'M, Oria CV, Sanchez-Guerrero J, Gomez-Pacheco L, Cabiedes J, Fernandez L, Ponce de Leon S (1990) Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective study of 500 consecutive patients. Medicine (Baltimore) 68:353?365","journal-title":"Medicine (Baltimore)"},{"key":"CR97","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0002-9343(89)90335-5","volume":"86","author":"RA Asherson","year":"1989","unstructured":"Asherson RA, Khamashta MA, Gil A, Vasquez JJ, Chan O, Baguley E, Hughes GRV (1989) Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disorders and the primary antiphospholipid syndrome. Am J Med 86:391?399","journal-title":"Am J Med"},{"key":"CR98","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00005792-198103000-00001","volume":"60","author":"KS Kant","year":"1981","unstructured":"Kant KS, Pollak VE, Weiss MA, Glueck HI, Miller MA, Hess EV (1981) Glomerular thrombosis in systemic lupus erythematosus: prevalence and significance. Medicine (Baltimore) 60:71?86","journal-title":"Medicine (Baltimore)"},{"key":"CR99","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0022-3476(81)80765-2","volume":"98","author":"JP Gillespie","year":"1981","unstructured":"Gillespie JP, Lindsley C, Linshaw MA, Richardson WP (1981) Childhood systemic lupus erythematosus with negative anti-nuclear antibody test. J Pediatr 98:578?581","journal-title":"J Pediatr"},{"key":"CR100","first-page":"340","volume":"9","author":"JL Enriquez","year":"1988\/89","unstructured":"Enriquez JL, Rajaraman S, Kalia A, Brouhard BH, Travis LB (1988\/89) Isolated antinuclear antibody negative lupus nephropathy in young children. Child Nephrol Urol 9:340?346","journal-title":"Child Nephrol Urol"},{"key":"CR101","first-page":"75","volume":"5","author":"MH Klein","year":"1984","unstructured":"Klein MH, Thorner PS, Yoon S-J, Poucell S, Baumal R (1984) Determination of circulating immune complexes, C3 and C4 complement components and anti DNA antibody in different classes of lupus nephritis. Int J Pediatr Nephrol 5:75?82","journal-title":"Int J Pediatr Nephrol"},{"key":"CR102","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0022-3476(76)80528-8","volume":"89","author":"BH Singsen","year":"1976","unstructured":"Singsen BH, Bernstein BH, King KK, Hanson V (1976) Systemic lupus erythematosus in childhood: correlations between changes in disease activity and serum complement levels. J Pediatr 89: 358?365","journal-title":"J Pediatr"},{"key":"CR103","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/anr.1780321109","volume":"32","author":"LD Kerr","year":"1989","unstructured":"Kerr LD, Adelberg BR, Schulman P, Spiera H (1989) Factor B activation products in patients with systemic lupus erythematosus. Athritis Rheum 32:1406?1413","journal-title":"Athritis Rheum"},{"key":"CR104","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1056\/NEJM198506203122502","volume":"312","author":"RJ Falk","year":"1985","unstructured":"Falk RJ, Dalmasso AP, Kim Y, Lam S, Michael A (1985) Radioimmunoassay of the attack complex of complement in serum from patients with systemic lupus erythematosus. N Engl J Med 312:1594?1599","journal-title":"N Engl J Med"},{"key":"CR105","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0016-5085(19)33878-8","volume":"57","author":"M Sparberg","year":"1969","unstructured":"Sparberg M, Simon N, Greco F del (1969) Intrahepatic cholestasis due to azathioprine. Gastroenterology 57:439?441","journal-title":"Gastroenterology"},{"key":"CR106","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1001\/archinte.1987.00370050087015","volume":"147","author":"GA Kozeny","year":"1987","unstructured":"Kozeny GA, Barr W, Bansal VK, Vertuno LL, Fresco R, Robinson J, Hano JE (1987) Occurrence of renal tubular dysfunction in lupus nephritis. Arch Intern Med 147:891?895","journal-title":"Arch Intern Med"},{"key":"CR107","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000183123","volume":"36","author":"CK Yeung","year":"1984","unstructured":"Yeung CK, Wong KL, Ng RP, Ng WL (1984) Tubular dysfunction in systemic lupus erythematosus. Nephron 36:84?88","journal-title":"Nephron"},{"key":"CR108","first-page":"179","volume":"33","author":"KW Dreyling","year":"1990","unstructured":"Dreyling KW, Wanner C, Schollmeyer P (1990) Control of hyperkalemia with fludrocortisone in a patient with systemic lupus erythematosus. Clin Nephrol 33:179?183","journal-title":"Clin Nephrol"},{"key":"CR109","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/archinte.1988.00380020141019","volume":"148","author":"FO Lee","year":"1989","unstructured":"Lee FO, Quismorio FP, Troum OM, Anderson PW, Do YS, Hsueh WA (1989) Mechanisms of hyperkalemia in systemic lupus erythematosus. Arch Intern Med 148:397?401","journal-title":"Arch Intern Med"},{"key":"CR110","first-page":"563","volume":"7","author":"PN Malleson","year":"1989","unstructured":"Malleson PN (1989) The role of the renal biopsy in childhood onset systemic lupus erythematosus: a viewpoint. Clin Exp Rheumatol 7:563?566","journal-title":"Clin Exp Rheumatol"},{"key":"CR111","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/art.1780330708","volume":"33","author":"HC Nossent","year":"1990","unstructured":"Nossent HC, Henzen-Logmans SC, Vroom TM, Berden JHM, Swaak TJG (1990) Contribution of renal biopsy data in predicting outcome in lupus nephritis. Arthritis Rheum 33:970?976","journal-title":"Arthritis Rheum"},{"key":"CR112","doi-asserted-by":"crossref","first-page":"718","DOI":"10.7326\/0003-4819-96-6-718","volume":"96","author":"Q Whiting-O'Keefe","year":"1982","unstructured":"Whiting-O'Keefe Q, Henke JE, Shearn MA, Hopper J Jr, Biava CG, Epstein WV (1982) The information content from renal biopsy in systemic lupus erythematosus. Ann Intern Med 96: 718?723","journal-title":"Ann Intern Med"},{"key":"CR113","doi-asserted-by":"crossref","first-page":"723","DOI":"10.7326\/0003-4819-96-6-723","volume":"96","author":"Q Whiting-O'Keefe","year":"1982","unstructured":"Whiting-O'Keefe Q, Riccardi PJ, Henke JE, Shearn MA, Hopper J Jr, Epstein WV (1982) Recognition of information in renal biopsies of patients with lupus nephritis. Ann Intern Med 96: 723?727","journal-title":"Ann Intern Med"},{"key":"CR114","volume-title":"Renal disease: classification and atlas of glomerular diseases","author":"J Churg","year":"1982","unstructured":"Churg J, Sobin LH (1982) Renal disease: classification and atlas of glomerular diseases. Igaku Shoin, Tokyo"},{"key":"CR115","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0002-9343(83)90338-8","volume":"75","author":"HA Austin III","year":"1983","unstructured":"Austin HA III, Muenz LR, Joyce KM, Antonovych T, Kullik M, Klippel J, Decker J (1983) Prognostic factors in lupus nephritis Contribution of renal histologic data. Am J Med 75:382?391","journal-title":"Am J Med"},{"key":"CR116","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/ki.1989.276","volume":"36","author":"MM Schwartz","year":"1989","unstructured":"Schwartz MM, Bernstein J, Hill GS, Holley K, Phillips EA, and the Lupus Nephritis Study Group (1989) Predictive value of renal pathology in diffuse proliferative glomerulonephritis. Kidney Int 36:891?896","journal-title":"Kidney Int"},{"key":"CR117","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0002-9343(78)90180-8","volume":"64","author":"GS Hill","year":"1978","unstructured":"Hill GS, Hinglais N, Tron F, Bach J-F (1978) Systemic lupus erythematosus. Morphologic correlations with immunologic and clinical data at the time of biopsy. Am J Med 64:61?79","journal-title":"Am J Med"},{"key":"CR118","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/BF00858546","volume":"3","author":"JS Cameron","year":"1989","unstructured":"Cameron JS (1989) The treatment of lupus nephritis. Pediatr Nephrol 3:350?362","journal-title":"Pediatr Nephrol"},{"key":"CR119","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/art.1780220901","volume":"22","author":"DA Albert","year":"1979","unstructured":"Albert DA, Hadler NM, Ropes MW (1979) Does corticosteroid therapy affect the survival of patients with systemic lupus erythematosus? Arthritis Rheum 22:945?953","journal-title":"Arthritis Rheum"},{"key":"CR120","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0307-742X(21)00205-8","volume":"8","author":"D Adu","year":"1982","unstructured":"Adu D, Cameron JS (1982) Lupus nephritis. Clin Rheum Dis 8: 153?183","journal-title":"Clin Rheum Dis"},{"key":"CR121","first-page":"387","volume-title":"Progress in glomerulonephritis","author":"JS Cameron","year":"1979","unstructured":"Cameron JS (1979) The nephritis of systemic lupus erythematosus. In: Kincaid-Smith P, D'Apice AJP, Atkins RC (eds) Progress in glomerulonephritis. Wiley, New York, pp 387?423"},{"key":"CR122","first-page":"407","volume-title":"Clinical immunology of the kidney","author":"JS Cameron","year":"1983","unstructured":"Cameron JS (1983) The treatment of immunologically mediated renal disease. In: Zabriskie J, Fillit H, Villareal H, Becker EL (eds) Clinical immunology of the kidney. Wiley, New York, pp 407?440."},{"key":"CR123","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0889-857X(21)00947-9","volume":"14","author":"EM Ginzler","year":"1988","unstructured":"Ginzler EM, Schom K (1988) Outcome and prognosis in sytemic lupus erythematosus. Rheum Clin North Am 14:67?78","journal-title":"Rheum Clin North Am"},{"issue":"Suppl 1","key":"CR124","first-page":"170","volume":"2","author":"VE Pollak","year":"1982","unstructured":"Pollak VE, Dosekun AK (1982) Evaluation of treatment in lupus nephritis: effect of prednisone. Am J Kidney Dis 2 [Suppl 1]: 170?177","journal-title":"Am J Kidney Dis"},{"key":"CR125","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1001\/jama.1977.03280220040018","volume":"238","author":"JD Urman","year":"1977","unstructured":"Urman JD, Rothfield NF (1977) Corticosteroid treatment in systemic lupus erythematosus. Survival studies. JAMA 238: 2272?2276","journal-title":"JAMA"},{"key":"CR126","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/ki.1984.75","volume":"25","author":"HA Austin III","year":"1984","unstructured":"Austin HA III, Muenz LR, Joyce KM, Antonovych TT, Balow JF (1984) Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting outcome. Kidney Int 25: 689?695","journal-title":"Kidney Int"},{"key":"CR127","first-page":"251","volume":"3","author":"RM Holleraft","year":"1976","unstructured":"Holleraft RM, Dubois EL, Lundberg GD, Chandor SB, Gilbert SB, Quismorio FP, Barbour BH, Fria GJ (1976) Renal change in systemic lupus erythematosus with normal renal function. J Rheumatol 3:251?261","journal-title":"J Rheumatol"},{"key":"CR128","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/ard.44.6.415","volume":"44","author":"JR O'Dell","year":"1985","unstructured":"O'Dell JR, Hays RC, Guggenheim SJ, Steigerwald JC (1985) Systemic lupus erythematosus without clinical renal abnormalities: renal biopsy findings and clinical course. Ann Rheum Dis 44:415?419","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 1","key":"CR129","first-page":"188","volume":"2","author":"DJ Leehey","year":"1982","unstructured":"Leehey DJ, Katz AI, Azaran AH, Aronson AJ, Spargo BH (1982) Silent diffuse lupus nephritis: long term follow-up. Am J Kidney Dis 2 [Suppl 1]:188?196","journal-title":"Am J Kidney Dis"},{"key":"CR130","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00005792-197711000-00007","volume":"56","author":"JV Donadio","year":"1977","unstructured":"Donadio JV, Burgess JH, Holley KE (1977) Membranous lupus nephropathy: a clinicopathologic study. Medicine (Baltimore) 56: 527?536","journal-title":"Medicine (Baltimore)"},{"key":"CR131","first-page":"209","volume":"53","author":"F Wang","year":"1984","unstructured":"Wang F, Looi LM (1984) Systemic lupus erythematosus with membranous nephropathy in Malaysian patients. Q J Med 53: 209?226","journal-title":"Q J Med"},{"key":"CR132","first-page":"537","volume":"64","author":"VE Pollak","year":"1964","unstructured":"Pollak VE, Pirani CL, Schwartz FD (1964) The natural history of the renal manifestations of systemic lupus erythematosus. J Lab Clin Med 64:537?550","journal-title":"J Lab Clin Med"},{"key":"CR133","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/art.1780080208","volume":"8","author":"K Lange","year":"1965","unstructured":"Lange K, Ores R, Strauss W, Wachstein M (1965) Steroid therapy of systemic lupus erythematosus based on immunological considerations. Arthritis Rheum 8:244?259","journal-title":"Arthritis Rheum"},{"key":"CR134","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1001\/archpedi.1965.02090030316016","volume":"110","author":"FG Smith","year":"1965","unstructured":"Smith FG, Witman N, Latta H (1965) Lupus glomerulonephritis. The effect of large doses of corticosteroids on renal function and renal lesions in children. Am J Dis Child 110:302?308","journal-title":"Am J Dis Child"},{"key":"CR135","first-page":"163","volume":"I","author":"ES Cathcart","year":"1974","unstructured":"Cathcart ES, Idelson BA, Scheinberg MA, Couser WG (1974) Beneficial effects of methylprednisolone ?pulse? therapy in diffuse proliferative nephritis. Lancet I:163?166","journal-title":"Lancet"},{"key":"CR136","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/BF00439243","volume":"145","author":"EH Garin","year":"1986","unstructured":"Garin EH, Sleasman HW, Richard GA, Fennell RS (1986) Pulsed methylprednisolone therapy compared to high dose prednisone in systemic lupus erythematosus. Eur J Pediatr 145:380?383","journal-title":"Eur J Pediatr"},{"key":"CR137","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1136\/ard.47.6.496","volume":"47","author":"CG Mackworth Young","year":"1988","unstructured":"Mackworth Young CG, David J, Morgan SH, Hughes GRV (1988) A double blind, placebo controlled trial of intravenous methylprednisolone in systemic lupus erythematosus. Ann Rheum Dis 47:496?502","journal-title":"Ann Rheum Dis"},{"key":"CR138","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/ard.41.4.347","volume":"41","author":"DA Isenberg","year":"1982","unstructured":"Isenberg DA, Morrow WJW, Snaith MC (1982) Methylprednisolone pulse therapy in the treatment of systemic lupus erythematosus. Ann Rheum Dis 41:347?351","journal-title":"Ann Rheum Dis"},{"key":"CR139","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF00870376","volume":"2","author":"N Ueda","year":"1988","unstructured":"Ueda N, Yoshikawa T, Chihara M, Kawaguchi S, Niinomi Y, Yasaki T (1988) Atrial fibrillation following methylprednisolone pulse therapy. Pediatr Nephrol 2:29?31","journal-title":"Pediatr Nephrol"},{"key":"CR140","first-page":"41","volume":"11","author":"A Bettinelli","year":"1991","unstructured":"Bettinelli A, Paterlini G, Mazzucchi E, Giani M (1991) Seizures and transient blindness following intravenous pulse methylprednisolone in children with primary glomerulonephritis. Child Urol Nephrol 11:41?43","journal-title":"Child Urol Nephrol"},{"key":"CR141","doi-asserted-by":"crossref","first-page":"511","DOI":"10.7326\/0003-4819-72-4-511","volume":"72","author":"GL Ackerman","year":"1970","unstructured":"Ackerman GL (1970) Alternate day steroid therapy in lupus nephritis. Ann Intern Med 72:511?519","journal-title":"Ann Intern Med"},{"key":"CR142","first-page":"418","volume":"25","author":"JS Cameron","year":"1976","unstructured":"Cameron JS, Lessof MH, Ogg CS, Williams BD, Williams DG (1976) Disease activity in the nephritis of systemic lupus erythematosus in relation to serum complement concentrations, DNA-binding capacity and precipitating anti-DNA antibody. Clin Exp Immunol 25:418?427","journal-title":"Clin Exp Immunol"},{"key":"CR143","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00005792-197605000-00003","volume":"55","author":"L Wagner","year":"1976","unstructured":"Wagner L (1976) Immunosuppressive agents in lupus nephritis: a critical analysis. Medicine (Baltimore) 55:239?250","journal-title":"Medicine (Baltimore)"},{"key":"CR144","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1056\/NEJM198412133112402","volume":"311","author":"DT Felson","year":"1984","unstructured":"Felson DT, Anderson J (1984) Evidence for the superiority of immunosuppressive drugs and prednisone over prednisone alone in lupus nephritis. N Engl J Med 311:1528?1533","journal-title":"N Engl J Med"},{"key":"CR145","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJM198603063141004","volume":"314","author":"HA Austin III","year":"1986","unstructured":"Austin HA III, Klippel JH, Balow JE, Riche NGH le, Steinberg A, Plotz PA, Decker JL (1986) Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. N Engl J Med 314:614?619","journal-title":"N Engl J Med"},{"key":"CR146","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/art.1780340803","volume":"34","author":"AD Steinberg","year":"1991","unstructured":"Steinberg AD, Steinberg SC (1991) Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisolone alone. Arthritis Rheum 34:945?950","journal-title":"Arthritis Rheum"},{"key":"CR147","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJM198408233110802","volume":"311","author":"JE Balow","year":"1984","unstructured":"Balow JE, Austin HA, Muenz LR, Joyce KM, Antonovych TT, Klippel JH, Steinberg AD, Plotz PH, Decker JL (1984) Effect of treatment on the evolution of renal abnormalities in lupus nephritis. N Engl J Med 311:491?495","journal-title":"N Engl J Med"},{"key":"CR148","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1056\/NEJM197508072930604","volume":"293","author":"RL Wall","year":"1975","unstructured":"Wall RL, Clausen KP (1975) Carcinoma of the urinary bladder in patients receiving cyclophosphamide. N Engl J Med 293: 271?273","journal-title":"N Engl J Med"},{"key":"CR149","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1001\/archinte.1979.03630410067021","volume":"139","author":"H Grunwald","year":"1979","unstructured":"Grunwald H, Rosner F (1979) Acute leukemia and immunosuppressive drug therapy for non-neoplastic diseases. Arch Intern Med 139:461?466","journal-title":"Arch Intern Med"},{"key":"CR150","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S0140-6736(81)92348-5","volume":"I","author":"RS Trompeter","year":"1981","unstructured":"Trompeter RS, Evans PR, Barratt TM (1981) Gonadal function in boys with steroid-responsive nephrotic syndrome treated with cyclophosphamide for short periods. Lancet I:1177?1179","journal-title":"Lancet"},{"key":"CR151","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/art.1780310402","volume":"31","author":"TJ Stilwell","year":"1988","unstructured":"Stilwell TJ, Benson RC, Remee RA de, McDonald TJ, Weiland LH (1988) Cyclophosphamide induced bladder toxicity in Wegener's granulomatosis. Arthritis Rheum 31:465?470","journal-title":"Arthritis Rheum"},{"key":"CR152","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/art.1780170205","volume":"17","author":"WV Epstein","year":"1974","unstructured":"Epstein WV, Grausz H (1974) Favorable outcome in diffuse proliferative glomerulonephritis of systemic lupus erythematosus. Arthritis Rheum 17:129?142","journal-title":"Arthritis Rheum"},{"key":"CR153","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1136\/bmj.2.5860.197","volume":"2","author":"ML Snaith","year":"1973","unstructured":"Snaith ML, Holt JM, Oliver DO, Dunhill MO, Halley W, Stephenson AC (1973) Treatment of patients with systemic lupus erythematosus including nephritis with chlorambucil. BMJ 2: 197?201","journal-title":"BMJ"},{"key":"CR154","first-page":"1055","volume":"296","author":"JS Cameron","year":"1977","unstructured":"Cameron JS (1977) Chlorambucil and leukemia (letter). N Engl J Med 296:1055","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"CR155","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/ndt\/5.suppl_1.58","volume":"5","author":"JE Balow","year":"1990","unstructured":"Balow JE (1990) Treatment and monitoring of patients with lupus nephritis. Nephrol Dial Transplant 5 [Suppl 1]:58?59","journal-title":"Nephrol Dial Transplant"},{"key":"CR156","first-page":"345A","volume":"29","author":"Y Kimura","year":"1991","unstructured":"Kimura Y, Foeldyari I, Jacobs JC (1991) Azathioprine is a valuable agent in the treatment of pediatric lupus (abstract). Pediatr Res 29:345A","journal-title":"Pediatr Res"},{"key":"CR157","first-page":"263","volume":"28","author":"C Ponticelli","year":"1987","unstructured":"Ponticelli C, Zucchelli P, Moroni G, Cagnoli L, Banfi G, Pasquali S (1987) Long-term prognosis of diffuse lupus nephritis. Clin Nephrol 28:263?271","journal-title":"Clin Nephrol"},{"key":"CR158","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0022-3476(89)80463-9","volume":"114","author":"TJA Lehman","year":"1989","unstructured":"Lehman TJA, Sherry DD, Wagner-Weiner L, McCurdy DK, Emery HM, Magilavy DB, Kovalevsky A (1989) Intermittent intravenous cyclophosphamide therapy for lupus nephritis. J Pediatr 114:1055?1060","journal-title":"J Pediatr"},{"key":"CR159","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1002\/art.1780311212","volume":"31","author":"RB Gibbons","year":"1988","unstructured":"Gibbons RB, Westerman E (1988) Acute nonlymphocytic leukemia following short term, intermittent intravenous cyclophosphamide treatment of lupus nephritis. Arthritis Rheum 31:1552?1554","journal-title":"Arthritis Rheum"},{"key":"CR160","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/art.1780210107","volume":"21","author":"E Ginzler","year":"1978","unstructured":"Ginzler E, Diamond H, Kaplan D, Weiner M, Schlesinger M, Seleznick M (1978) Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus. Arthritis Rheum 21:37?44","journal-title":"Arthritis Rheum"},{"key":"CR161","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJM197301182880303","volume":"288","author":"E Sharon","year":"1973","unstructured":"Sharon E, Kaplan D, Diamond HS (1973) Exacerbation of systemic lupus erythematosus after withdrawal of azathioprine therapy. N Engl J Med 288:122?124","journal-title":"N Engl J Med"},{"key":"CR162","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1136\/bmj.2.6203.1461","volume":"2","author":"LJ Kinlen","year":"1979","unstructured":"Kinlen LJ, Sheil AGR, Peto J, Doll R (1979) Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppression. BMJ 2:1461?1466","journal-title":"BMJ"},{"key":"CR163","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/art.1780150207","volume":"15","author":"EA Lipsmeyer","year":"1972","unstructured":"Lipsmeyer EA (1972) Development of malignant cerebral lymphoma in a patient with systemic lupus erythematosus treated with immunosuppression. Arthritis Rheum 15:183?186","journal-title":"Arthritis Rheum"},{"key":"CR164","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S0016-5085(72)80121-5","volume":"62","author":"JH Nogueira","year":"1972","unstructured":"Nogueira JH, Freedman MA (1972) Acute pancreatitis as a complication of Imuran therapy in regional enteritis. Gastroenterology 62:1040?1041","journal-title":"Gastroenterology"},{"key":"CR165","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0016-5085(19)33878-8","volume":"57","author":"M Sparberg","year":"1969","unstructured":"Sparberg M, Simon N, Greco F del (1969) Intrahepatic cholestasis due to azathioprine. Gastoenterology 57:439?441","journal-title":"Gastoenterology"},{"key":"CR166","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/0140-6736(92)92292-N","volume":"340","author":"DT Boumpas","year":"1992","unstructured":"Boumpas DT, Austin HA III, Vaughn EM, Klippel JH, Steinberg AD, Yarboro CH, Balow JE (1992) Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet 340:741?745","journal-title":"Lancet"},{"key":"CR167","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/art.1780310505","volume":"31","author":"RJ Rothenberg","year":"1988","unstructured":"Rothenberg RJ, Graziano FM, Gandone JT, Goldberg JW, Bjarnason DF, Finesilver AG (1988) The use of methotrexate in steroid resistant systemic lupus erythematosus. Arthritis Rheum 31:612?615","journal-title":"Arthritis Rheum"},{"key":"CR168","first-page":"236","volume":"25","author":"BR Leaker","year":"1986","unstructured":"Leaker BR, Becker GJ, Dowling JP, Kincaid Smith P (1986) Rapid improvement in severe lupus glomerular lesions following intensive plasma exchange associated with immunosuppression. Clin Nephrol 25:236?244","journal-title":"Clin Nephrol"},{"key":"CR169","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1056\/NEJM199205213262101","volume":"326","author":"EJ Lewis","year":"1992","unstructured":"Lewis EJ, Hunsicker LG, Lan S-P, Rohde RD, Lachin JM (1992) A controlled trial of plasmapheresis therapy in severe lupus nephritis. N Engl J Med 326:1373?1379","journal-title":"N Engl J Med"},{"key":"CR170","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0140-6736(83)91561-1","volume":"1","author":"N Wei","year":"1983","unstructured":"Wei N, Klippel JH, Huston DP, Hall RP, Lawley TJ, Balow JE, Steinberg AD, Decker EL (1983) Randomized trial of plasma exchange in mild systemic lupus erythematosus. Lancet 1:17?21","journal-title":"Lancet"},{"key":"CR171","first-page":"270","volume":"18","author":"PC Dau","year":"1991","unstructured":"Dau PC, Callahan J, Parker R, Golbus J (1991) Immunologic effects of plasmapheresis synchronized with pulse cyclophosphamide in systemic lupus erythematosus. J Rheumatol 18: 270?276","journal-title":"J Rheumatol"},{"key":"CR172","doi-asserted-by":"crossref","first-page":"344","DOI":"10.7326\/0003-4819-107-2-344","volume":"107","author":"JO Schroeder","year":"1987","unstructured":"Schroeder JO, Euler HH, Loffler H (1987) Synchronization of plasmapheresis and pulse cyclophosphamide in severe systemic lupus erythematosus. Ann Intern Med 107:344?346","journal-title":"Ann Intern Med"},{"key":"CR173","first-page":"20","volume":"16","author":"WF Clark","year":"1981","unstructured":"Clark WF, Lindsay RM, Ulan RA, Cordy PE, Linton AL (1981) Chronic plasma exchange therapy in SLE nephritis. Clin Nephrol 16:20?23","journal-title":"Clin Nephrol"},{"key":"CR174","first-page":"1","volume":"51","author":"J Cohen","year":"1982","unstructured":"Cohen J, Pinching AJ, Rees AJ, Peters DK (1982) Infection and immunosuppression. A study of the infective complications of 75 patients with immunologically-mediated disease. Q J Med 51: 1?15","journal-title":"Q J Med"},{"key":"CR175","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1001\/jama.1980.03310210025020","volume":"244","author":"EJ Wing","year":"1980","unstructured":"Wing EJ, Bruns FJ, Fraley DS, Segel DP, Adler S (1980) Infectious complications with plasmapheresis in rapidly progressive glomerulonephritis. JAMA 244:2423?2426","journal-title":"JAMA"},{"key":"CR176","doi-asserted-by":"crossref","first-page":"924","DOI":"10.7326\/0003-4819-114-11-924","volume":"114","author":"MA Pohl","year":"1991","unstructured":"Pohl MA, Lan S-P, Berl T, and the lupus nephritis collaborative study group (1991) Plasmapheresis does not increase the risk for infection in immunosuppressed patients with severe lupus nephritis. Ann Intern Med 114:924?929","journal-title":"Ann Intern Med"},{"key":"CR177","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/BF00849223","volume":"1","author":"SC Jordan","year":"1987","unstructured":"Jordan SC, Ho W, Ettenger R, Salusky IB, Fine RN (1987) Plasma exchange improves the glomerulonephritis of systemic lupus erythematosus in selected pediatric patients. Pediatr Nephrol 1:276?280","journal-title":"Pediatr Nephrol"},{"key":"CR178","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/qjmed\/81.3.975","volume":"81","author":"DT Boumpas","year":"1992","unstructured":"Boumpas DT, Yamada H, Patronas NJ, Scott D, Klippel JH, Balow JE (1992) Pulse cyclophosphamide for severe neuropsychiatric lupus. Q J Med 81:975?984","journal-title":"Q J Med"},{"key":"CR179","volume-title":"Haemostasis and renal disease","year":"1988","unstructured":"Remuzzi G, Rossi E (eds) (1988) Haemostasis and renal disease. Butterworth, London"},{"key":"CR180","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000180176","volume":"10","author":"R Cade","year":"1973","unstructured":"Cade R, Spooner G, Schlein G, Pickering M, Quesada A de, Holcomb A, Juncos L, Richard G, Sivres O, Levin D, Hackett R, Free J, Hunt R, Fregly M (1973) Comparison of azathioprine, prednisolone and heparin alone or combined in treating lupus nephritis. Nephron 10:37?56","journal-title":"Nephron"},{"key":"CR181","first-page":"333","volume":"4?5","author":"J Conte","year":"1973","unstructured":"Conte J, Mignon-Conte M, Suc J-M (1973) R\u00e9flexions critiques sur le traitement de la n\u00e9phropathie lupique. Etude compar\u00e9e de l'action des cortico\u00efdes, de l'association indomethacine-anti-palud\u00e9en de synthese, et de l'heparine. J Urol Nephrol 4?5: 333?350","journal-title":"J Urol Nephrol"},{"key":"CR182","first-page":"164","volume":"14","author":"A Parbtani","year":"1980","unstructured":"Parbtani A, Frampton G, Kasai N, Yewdall V, Cameron JS (1980) Platelet and plasma serotonin concentrations in glomerulone-phritis III. The nephritis of systemic lupus erythematosus. Clin Nephrol 14:164?172","journal-title":"Clin Nephrol"},{"key":"CR183","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archinte.1984.00350130043009","volume":"144","author":"AK Dosekun","year":"1984","unstructured":"Dosekun AK, Pollak VE, Glas-Greenwalt P, Kant S, Penovich P, Lebron Berger A, Weiss MA, Levinson JE (1984) Anterod in systemic lupus erythematosus with thrombosis. Clinical and fibrinolytic effect. Arch Intern Med 144:37?42","journal-title":"Arch Intern Med"},{"key":"CR184","first-page":"77","volume":"105","author":"KS Kant","year":"1982","unstructured":"Kant KS, Pollak VE, Dosekun AK, Glas-Greenwalt P, Weiss MA, Glueck RI (1982) Lupus nephritis with thrombosis and abnormal fibrinolysis: effect of ancrod. J Lab Clin Med 105:77?88","journal-title":"J Lab Clin Med"},{"key":"CR185","first-page":"879","volume":"69","author":"S Kim","year":"1988","unstructured":"Kim S, Wadwha NK, Kant KS, Pollak VE, Glas-Greenwalt P, Weiss MA, Hong CD (1988) Fibrinolysis in glomerulonephritis treated with ancrod: renal functional, immunologic and histopathologic effects. Q J Med 69:879?895","journal-title":"Q J Med"},{"key":"CR186","doi-asserted-by":"crossref","first-page":"336","DOI":"10.7326\/0003-4819-89-3-336","volume":"89","author":"RP Kimberly","year":"1978","unstructured":"Kimberly RP, Gill JR, Bowden RE, Keiser HR, Plotz PH (1978) Elevated urinary prostaglandins and the effects of aspirin in lupus erythematosus. Ann Intern Med 89:336?341","journal-title":"Ann Intern Med"},{"key":"CR187","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/0002-9343(84)90849-0","volume":"76","author":"WL Bender","year":"1984","unstructured":"Bender WL, Whelton A, Beschorner WE, Darwish MO, Hall-Craggs M, Solez K (1984) Interstitial nephritis, proteinuria, and renal failure caused by non-steroidal anti-inflammatory drugs. Immunologic characterization of the inflammatory infiltrate. Am J Med 76:1006?1012","journal-title":"Am J Med"},{"key":"CR188","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJM198902163200703","volume":"320","author":"A Pierucci","year":"1989","unstructured":"Pierucci A, Simonetti BM, Pecci G, Mavrikakis G, Feriozzi S, Cinotti GA, Patrigiani P, Ciabattoni G, Patrono C (1989) Improvement of renal function with selective thromboxane antagonism in lupus nephritis. N Engl J Med 320:421?425","journal-title":"N Engl J Med"},{"key":"CR189","first-page":"61","volume":"34","author":"S Hariharan","year":"1990","unstructured":"Hariharan S, Pollak VE, Kant KS, Weiss MA, Wadhwa NK (1990) Diffuse proliferative lupus nephritis: long-term observations in patients treated with ancrod. Clin Nephrol 34:61?69","journal-title":"Clin Nephrol"},{"key":"CR190","first-page":"359","volume":"54","author":"D Israel-Biet","year":"1983","unstructured":"Israel-Biet D, Noel L-H, Bach MA, Dardenne M, Bach JF (1983) Marked reduction of DNA antibody and glomerulopathy in thymulin or cyclosporin A-treated (NZB X NZW) mice. Clin Exp Immunol 54:359?365","journal-title":"Clin Exp Immunol"},{"issue":"Suppl 1","key":"CR191","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000168040","volume":"9","author":"H Favre","year":"1989","unstructured":"Favre H, Miescher PA, Huang YP, Chatelanat F, Mihatsch MJ (1989) Ciclosporin in the treatment of lupus nephritis. Am J Nephrol 9 [Suppl 1]:57?60","journal-title":"Am J Nephrol"},{"key":"CR192","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0022-3476(87)80057-4","volume":"111","author":"G Feutren","year":"1987","unstructured":"Feutren G, Querin S, Noel LH, Chatenoud L, Beaurain G, Lesavre P, Bach JF (1987) Effects of cyclosporine in severe systemic lupus erythematosus. J Pediatr 111:1063?1068","journal-title":"J Pediatr"},{"key":"CR193","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/ki.1984.160","volume":"26","author":"N Francois Le","year":"1984","unstructured":"Le Francois N, Deleix P, Laville M, Zech P, Traeger J (1984) Treatment of lupus nephritis with cyclosporin A: a patient with a 1 year follow-up (abstract). Kidney Int 26:225","journal-title":"Kidney Int"},{"key":"CR194","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/ndt\/4.11.923","volume":"4","author":"A Meyrier","year":"1989","unstructured":"Meyrier A (1989) Treatment of glomerular disease with cyclosporin A. Nephrol Dial Transplant 4:923?931","journal-title":"Nephrol Dial Transplant"},{"key":"CR195","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/0090-1229(89)90211-0","volume":"51","author":"K Takabayashi","year":"1989","unstructured":"Takabayashi K, Koike T, Kurasawa K, Matsumua R, Sato T, Tomioka H, Ito I, Yoshiki T, Yoshida S (1989) Effect of FK-506, a novel immunosuppressive drug, on murine systemic lupus erythematosus. Clin Immunol Immunopathol 51:110?117","journal-title":"Clin Immunol Immunopathol"},{"key":"CR196","first-page":"629","volume":"30","author":"B Leaker","year":"1986","unstructured":"Leaker B, Quist R, Salehi N, Kincaid Smith PS (1986) The effect of eicosapentanoic acid on active lupus nephritis (abstract). Kidney Int 30:629","journal-title":"Kidney Int"},{"key":"CR197","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/ki.1989.242","volume":"36","author":"WF Clark","year":"1989","unstructured":"Clark WF, Parbtani A, Huff MW, Reid B, Holub BJ, Falardeau P (1989) Omega-3 fatty acid dietary supplementation in patients with systemic lupus erythematosus (SLE). Kidney Int 36: 653?660","journal-title":"Kidney Int"},{"key":"CR198","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/ard.50.7.463","volume":"50","author":"AJE Walton","year":"1991","unstructured":"Walton AJE, Snaith ML, Locniskar M, Cumberland AG, Morrow WJW, Isenberg DA (1991) Dietary fish oil and the severity of symptoms in patients with systemic lupus erythematosus. Ann Rheum Dis 50:463?466","journal-title":"Ann Rheum Dis"},{"key":"CR199","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0002-9343(81)90532-5","volume":"70","author":"YS Haider","year":"1981","unstructured":"Haider YS, Roberts WC (1981) Coronary arterial disease in systemic lupus erythematosus. Am J Med 70:775?781","journal-title":"Am J Med"},{"key":"CR200","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1136\/bmj.290.6462.126","volume":"290","author":"P Correia","year":"1985","unstructured":"Correia P, Cameron JS, Lian JD, Hicks J, Ogg CS, Williams DG, Chantler C, Haycock G (1985) Why do patients with lupus nephritis die? BMJ 290:126?131","journal-title":"BMJ"},{"key":"CR201","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3109\/03009749009102117","volume":"19","author":"G Westberg","year":"1990","unstructured":"Westberg G, Tarkowski A (1990) Effect of maxEPA in patients with SLE. Scand J Rheumatol 19:137?143","journal-title":"Scand J Rheumatol"},{"key":"CR202","first-page":"111","volume":"15","author":"R El-Habib","year":"1984","unstructured":"El-Habib R, Laville M, Traeger J (1984) Specific adsorption of circulating antibodies by extracorporeal plasma perfusions over antigen coated collagen flat membranes: applications to systemic lupus erythematosus. J Clin Lab Immunol 15:111?117","journal-title":"J Clin Lab Immunol"},{"key":"CR203","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0140-6736(88)92553-6","volume":"II","author":"A Palmer","year":"1988","unstructured":"Palmer A, Gjorstrup P, Severn A, Welsh K, Taube D (1988) Treatment of systemic lupus erythematosus by extracorporeal immunoadsorption (letter). Lancet II:272","journal-title":"Lancet"},{"key":"CR204","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0140-6736(79)92177-9","volume":"II","author":"DS Terman","year":"1979","unstructured":"Terman DS, Buffaloe G, Mattioli C, Cook G, Tillquist R, Sullivan M, Ayus JC (1979) Extracorporeal immunoadsorption: initial experience in human systemic lupus erythematosus. Lancet II: 824?827","journal-title":"Lancet"},{"key":"CR205","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF00918189","volume":"10","author":"SA Schwartz","year":"1990","unstructured":"Schwartz SA (1990) Intravenous immunoglobulin (IVIG) for the therapy of autoimmune disorders. J Clin Immunol 10:81?89","journal-title":"J Clin Immunol"},{"issue":"Suppl","key":"CR206","doi-asserted-by":"crossref","first-page":"S164","DOI":"10.1016\/0090-1229(89)90082-2","volume":"53","author":"SC Jordan","year":"1989","unstructured":"Jordan SC (1989) Intravenous ? globulin therapy in systemic lupus erythematosus and immune complex disease. Clin Immunol Immunopathol 53 [Suppl]:S164-S169","journal-title":"Clin Immunol Immunopathol"},{"key":"CR207","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000185772","volume":"53","author":"C-Y Lin","year":"1989","unstructured":"Lin C-Y, Hsu H-C, Chiang H (1989) Improvement in histological and immunological change in steroid and immunosuppressive drug-resistant lupus nephritis by high-dose intravenous gamma globulin. Nephron 53:303?310","journal-title":"Nephron"},{"key":"CR208","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0140-6736(91)93395-P","volume":"337","author":"J Schifferli","year":"1991","unstructured":"Schifferli J, Leski M, Favre H, Imbach P, Nydegger U, Davies K (1991) High dose intravenous IgG treatment and renal function. Lancet 337:457?458","journal-title":"Lancet"},{"key":"CR209","doi-asserted-by":"crossref","first-page":"450","DOI":"10.7326\/0003-4819-102-4-450","volume":"102","author":"S Strober","year":"1985","unstructured":"Strober S, Field E, Hoppe RT, Kotzin BL, Shemesh O, Engelman E, Ross JC, Myers BD (1985) Treatment of intractable lupus nephritis with total lymphoid irradiation. Ann Intern Med 102: 450?458","journal-title":"Ann Intern Med"},{"key":"CR210","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0022-3476(87)80055-0","volume":"111","author":"S Strober","year":"1987","unstructured":"Strober S (1987) Total lymphoid irradiation in alloimmunity and autoimmunity. J Pediatr 111:1051?1055","journal-title":"J Pediatr"},{"key":"CR211","doi-asserted-by":"crossref","first-page":"689","DOI":"10.7326\/0003-4819-107-5-689","volume":"197","author":"S Strober","year":"1987","unstructured":"Strober S, Farinas MC, Field EH, Salovera JT, Kiberd BA, Myers BD, Hoppe RT (1987) Lupus nephritis after total lymphoid irradiation. Persistent improvement and reduction in steroid dosage. Ann Intern Med 197:689?691","journal-title":"Ann Intern Med"},{"key":"CR212","doi-asserted-by":"crossref","first-page":"548","DOI":"10.7326\/0003-4819-115-7-548","volume":"115","author":"AD Steinberg","year":"1991","unstructured":"Steinberg AD, Gourley MF, Klinman DM, Tsokos GC, Scott DE, Krieg AM (1991) NIH conference: systemic lupus erythematosus. Ann Intern Med 115:548?559","journal-title":"Ann Intern Med"},{"key":"CR213","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1172\/JCI110927","volume":"71","author":"B Hahn","year":"1981","unstructured":"Hahn B, Ebling FM (1981) Suppression of NZB\/NZW murine nephritis by administration of a syngeneic monoclonal antibody to DNA. J Clin Invest 71:1728?1736","journal-title":"J Clin Invest"},{"key":"CR214","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4049\/jimmunol.132.1.187","volume":"132","author":"BH Hahn","year":"1984","unstructured":"Hahn BH, Ebling FM (1984) Suppression of murine lupus nephritis by administration of an anti-idiotypic antibody to anti-DNA. J Immunol 132:187?190","journal-title":"J Immunol"},{"key":"CR215","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.4049\/jimmunol.138.10.3247","volume":"138","author":"D Wofsy","year":"1987","unstructured":"Wofsy D, Seaman WE (1987) Reversal of advanced murine lupus in NZB\/NZW F1 mice with monoclonal antibody to L3T4. Immunol 138:3247?3253","journal-title":"Immunol"},{"key":"CR216","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1084\/jem.158.4.1350","volume":"158","author":"NE Adelman","year":"1983","unstructured":"Adelman NE, Watling DL, McDevitt HO (1983) Treatment of (NZB X NZW) F1 disease with anti I-A monclonal antibodies. J Exp Med 158:1350?1355","journal-title":"J Exp Med"},{"key":"CR217","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0090-1229(06)80003-6","volume":"61","author":"AO Vladitiu","year":"1991","unstructured":"Vladitiu AO (1991) Treatment of autoimmune diseases with antibodies to class II major histocompatibility complex antigens. Clin Immunol Immunopathol 61:1?17","journal-title":"Clin Immunol Immunopathol"},{"key":"CR218","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4049\/jimmunol.140.1.59","volume":"140","author":"VE Kelley","year":"1988","unstructured":"Kelley VE, Gaulton GN, Hattori M, Ikegami H, Eisenbarth G, Strom TB (1988) Anti-interleukin 2 receptor antibody suppresses murine diabetic insulitis and lupus nephritis. J Immunol 140: 59?61","journal-title":"J Immunol"},{"key":"CR219","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0167-5699(90)90148-3","volume":"11","author":"L Adorini","year":"1990","unstructured":"Adorini L, Barnaba V, Bona C, Celada F, Lanzavecchia A, Sercarz E, Suciu-Foca N, Wekerle H (1990) New perspectives on immunointervention in autoimmune diseases. Immunol Today 11:383?386","journal-title":"Immunol Today"},{"key":"CR220","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0167-5699(91)90048-X","volume":"12","author":"G Kinglsey","year":"1991","unstructured":"Kinglsey G, Panayi G, Lanchbury J (1991) Immunotherapy of rheumatic diseases-practice and prospects. Immunol Today 12: 177?179","journal-title":"Immunol Today"},{"key":"CR221","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/0952-7915(89)90054-X","volume":"1","author":"O Pankewycz","year":"1989","unstructured":"Pankewycz O, Strom TB, Kelley VE (1989) Therapeutic strategies using monoclonal antibodies in autoimmune disease. Curr Opinion Immunol 1:757?763","journal-title":"Curr Opinion Immunol"},{"key":"CR222","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/349293a0","volume":"349","author":"G Winter","year":"1991","unstructured":"Winter G, Milstein C (1991) Man-made antibodies. Nature 349: 293?299","journal-title":"Nature"},{"key":"CR223","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1073\/pnas.85.11.3980","volume":"85","author":"VE Kelley","year":"1988","unstructured":"Kelley VE, Bacha P, Pankewycz O, Nichols JC, Murphy JR, Strom TB (1988) Interleukin 2-diphtheria toxin fusion protein can abolish cell-mediated immunity in vivo. Proc Natl Acad Sci USA 85:3980?3984","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR224","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1073\/pnas.85.6.1922","volume":"85","author":"H Lederboum-Glaski","year":"1988","unstructured":"Lederboum-Glaski H, FitzGerald D, Chaudhary V, Adhya S, Pastan I (1988) Cytotoxic activity of an interleukin 2-Pseudomonas exotoxin chimeric protein produced inEscherichia coli. Proc Natl Acad Sci USA 85, 1922?1926","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR225","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0002-9343(88)80366-8","volume":"85","author":"C Ponticelli","year":"1988","unstructured":"Ponticelli C, Moroni G, Banfi G, Ponticelli C (1988) Discontinuation of therapy in diffuse proliferative lupus nephritis (letter). Am J Med 85:275","journal-title":"Am J Med"},{"key":"CR226","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/ard.41.1.39","volume":"41","author":"ECS Tozman","year":"1982","unstructured":"Tozman ECS, Urowitz MB, Gladman DD (1982) Prolonged complete remission in previously severe SLE. Ann Rheum Dis 41:39?40","journal-title":"Ann Rheum Dis"},{"key":"CR227","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1002\/art.1780301202","volume":"30","author":"S Studenski","year":"1987","unstructured":"Studenski S, Allen NB, Caldwell DS, Rice JR, Pilisson RP (1987) Survival in systemic lupus erythematosus. A multivariate analysis of demographic factors. Arthritis Rheum 30:1326?1332","journal-title":"Arthritis Rheum"},{"key":"CR228","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/art.1780340918","volume":"34","author":"MH Liang","year":"1991","unstructured":"Liang MH, Partridge AJ, Daltroy LH, Straaton KV, Galper SR, Holman HR (1991) Strategies for reducing excess morbidity and mortality in blacks with systemic lupus erythematosus. Arthritis Rheum 34:1187?1196","journal-title":"Arthritis Rheum"},{"key":"CR229","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/0002-9343(87)90645-0","volume":"83","author":"GB Appel","year":"1987","unstructured":"Appel GB, Cohen DJ, Pirani CL, Melzer JI, Estes D (1987) Long term follow up of patients with lupus nephritis. A study based on the classification of the World Health Organization. Am J Med 83:877?885","journal-title":"Am J Med"},{"key":"CR230","first-page":"779","volume":"72","author":"JM Esdaile","year":"1989","unstructured":"Esdaile JM, Levinton C, Federgreen W, Hayslett JP, Kachgarian M (1989) The clinical an renal biopsy predictors of long-term outcome in lupus nephritis: a study of 87 patients and review of the literature. Q J Med 72:779?833","journal-title":"Q J Med"},{"key":"CR231","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0272-6386(12)80957-7","volume":"19","author":"Gruppo Italiano per lo Studio della Nefrite Lupica (GISNEL)","year":"1992","unstructured":"Gruppo Italiano per lo Studio della Nefrite Lupica (GISNEL) (1992) Lupus nephritis: prognostic factors and probability of maintaining life-supporting renal function 10 years after the diagnosis. Am J Kidney Dis 19:473?479","journal-title":"Am J Kidney Dis"},{"key":"CR232","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/art.1780250601","volume":"25","author":"EM Ginzler","year":"1982","unstructured":"Ginzler EM, Diamond HS, Weiner M, Schelsinger M, Fries JF, Wasner C, Medsger TA, Ziegler G, Klippel JH, Hadler NM, Alabert DA, Hess EV, Spencer-Green G, Grayzel A, Worth D, Hahn BH, Barnett EV (1982) A multicentre study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis. Arthritis Rheum 25:601?611","journal-title":"Arthritis Rheum"},{"key":"CR233","first-page":"163","volume":"62","author":"B Leaker","year":"1987","unstructured":"Leaker B, Fairley KF, Dowling J, Kincaid-Smith P (1987) Lupus nephritis: clinical and pathological correlation. Q J Med 62: 163?179","journal-title":"Q J Med"},{"key":"CR234","first-page":"434","volume":"38","author":"M L\u00e9vy","year":"1991","unstructured":"L\u00e9vy M (1991) Les evolutions d\u00e9favorables au cours du lupus \u00e9rythemateux diss\u00e9min\u00e9 de l'enfant. Ann Pediatr (Paris) 38: 434?439","journal-title":"Ann Pediatr (Paris)"},{"key":"CR235","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/art.1780240602","volume":"24","author":"MF Gordon","year":"1981","unstructured":"Gordon MF, Stolley PD, Schinnar K (1981) Trends in recent systemic lupus erythematosus mortality rates. Arthritis Rheum 24:762?769","journal-title":"Arthritis Rheum"},{"key":"CR236","first-page":"586","volume":"138","author":"DS Celermajer","year":"1984","unstructured":"Celermajer DS, Thorner PS, Baumal R, Arbus GS (1984) Sex differences in childhood lupus nephritis. Am J Dis Child 138: 586?588","journal-title":"Am J Dis Child"},{"key":"CR237","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/ki.1986.108","volume":"29","author":"PJ Rush","year":"1986","unstructured":"Rush PJ, Baumal R, Shore A, Balfe JW, Schreiber M (1986) Correlation of renal histology with outcome in children with lupus nephritis. Kidney Int 29:1066?1071","journal-title":"Kidney Int"},{"key":"CR238","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/ki.1972.67","volume":"2","author":"I Dujovne","year":"1972","unstructured":"Dujovne I, Pollak VE, Pirani CL, Dillard MG (1972) The distribution and character of glomerular deposits in systemic lupus erythematosus. Kidney Int 2:33?50","journal-title":"Kidney Int"},{"key":"CR239","first-page":"311","volume":"52","author":"S Tateno","year":"1983","unstructured":"Tateno S, Kobayashi Y, Shigematsu H, Hiki Y (1983) Study of lupus nephritis: its classification and the significance of subendothelial deposits. Q J Med 52:311?331","journal-title":"Q J Med"},{"key":"CR240","first-page":"1","volume":"36","author":"RC Muehrcke","year":"1957","unstructured":"Muehrcke RC, Kark RM, Pirani CL, Pollak VE (1957) Lupus nephritis: a clinical and pathologic study based on renal biopsies. Medicine (Baltimore) 36:1?119","journal-title":"Medicine (Baltimore)"},{"key":"CR241","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1159\/000184012","volume":"44","author":"MH Park","year":"1986","unstructured":"Park MH, D'Agati V, Appel GB, Pirani CL (1986) Tubulointerstitial disease in lupus nephritis: relation to immune deposits, interstitial inflammation, glomerular changes, renal function, and prognosis. Nephron 44:309?319","journal-title":"Nephron"},{"key":"CR242","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/ki.1988.211","volume":"34","author":"AB Magil","year":"1988","unstructured":"Magil AB, Puterman ML, Ballon HS, Chan V, Lierenman DS, Rae A, Sutton RAL (1988) Prognostic factors in diffuse proliferative lupus glomerulonephritis. Kidney Int 34:511?517","journal-title":"Kidney Int"},{"key":"CR243","first-page":"515","volume":"7","author":"M Abeles","year":"1980","unstructured":"Abeles M, Urman JD, Weinstein A, Lowenstein M, Rothfield NF (1980) Systemic lupus erythematosus in the younger patient\u00df: survival studies. J Rheumatol 7:515?522","journal-title":"J Rheumatol"},{"key":"CR244","first-page":"941","volume":"17","author":"S Lacks","year":"1990","unstructured":"Lacks S, White P (1990) Morbidity associated with childhood systemic lupus erythematosus. J Rheumatol 17:941?945","journal-title":"J Rheumatol"},{"key":"CR245","first-page":"274","volume":"22","author":"J Karsh","year":"1979","unstructured":"Karsh J, Klippel JH, Balow JE, Decker JL (1979) Mortality in lupus nephritis. Arthritis Rheum 22:274?769","journal-title":"Arthritis Rheum"},{"key":"CR246","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/art.1780250602","volume":"25","author":"S Rosner","year":"1982","unstructured":"Rosner S, Ginzler EM, Diamond HS, Weiner M, Schlesinger M, Fries JF, Wasner C, Medsger TA, Ziegler G, Klippel G, Klippel JH, Hadler NM, Albert DA, Hess EV, Spencer-Green G, Grayzel A, Worth D, Hahn BH, Barnett EV (1982) A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death. Arthritis Rheum 25:612?617","journal-title":"Arthritis Rheum"},{"key":"CR247","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.1780170102","volume":"17","author":"PJ Staples","year":"1974","unstructured":"Staples PJ, Gerding DN, Decker JL, Gordon RS (1974) Incidence of infection in systemic lupus erythematosus. Arthritis Rheum 17:1?10","journal-title":"Arthritis Rheum"},{"key":"CR248","first-page":"271","volume":"55","author":"O Nived","year":"1985","unstructured":"Nived O, Sturfelt G, Wollheim F (1985) Systemic lupus erythematosus and infection: a controlled and prospective study including epidemiological data. Q J Med 55:271?287","journal-title":"Q J Med"},{"key":"CR249","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1136\/ard.49.8.630","volume":"49","author":"K Nagasawa","year":"1990","unstructured":"Nagasawa K, Yamauchi Y, Tada Y, Kusaba T, Niho Y, Yoshikawa H (1990) High incidence of herpes zoster in patients with systemic lupus erythematosus: an immunological analysis. Ann Rheum Dis 49:630?633","journal-title":"Ann Rheum Dis"},{"key":"CR250","first-page":"655","volume":"10","author":"TJA Lehman","year":"1983","unstructured":"Lehman TJA, Palmeri ST, Hastings C, Klippel JH, Plotz PH (1983) Bacterial endocarditis complicating systemic lupus erythematosus. J Rheumatol 10:655?658","journal-title":"J Rheumatol"},{"key":"CR251","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1136\/ard.48.11.933","volume":"48","author":"P Haselaar","year":"1989","unstructured":"Haselaar P, Derksen RHWM, Blokzijl L, Hessing M, Nieuwenhuis HK, Bouma BN, Groot PG de (1989) Risk factors for thrombosis in lupus patients. Ann Rheum Dis 48:933?940","journal-title":"Ann Rheum Dis"},{"key":"CR252","first-page":"312","volume":"94","author":"E Angles-Cano","year":"1979","unstructured":"Angles-Cano E, Sultan Y, Clavel J (1979) Predisposing factors to thrombosis in systemic lupus erythematosus. Possible relation to endothelial cell damage. J Lab Clin Med 94:312?323","journal-title":"J Lab Clin Med"},{"key":"CR253","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1136\/ard.46.10.741","volume":"46","author":"MA Byron","year":"1987","unstructured":"Byron MA, Allington MJ, Chapel HM, Mowat AG, Cederhohn, Williams SA (1987) Indications of vascular cell endothelial cell dysfunction in systemic lupus erythematosus. Ann Rheum Dis 46:741?745","journal-title":"Ann Rheum Dis"},{"key":"CR254","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1172\/JCI111784","volume":"75","author":"EH Cole","year":"1985","unstructured":"Cole EH, Schulman J, Urowitz M, Keystone E, Williams C, Levy GA (1985) Monocyte procoagulant activity in glomerulonephritis associated with systemic lupus erythematosus. J Clin Invest 75: 861?868","journal-title":"J Clin Invest"},{"key":"CR255","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0272-6386(85)80019-6","volume":"6","author":"J Gelfand","year":"1985","unstructured":"Gelfand J, Truong L, Stern L, Pirani CL, Appel GB (1985) Thrombotic thrombocytopenic purpura syndrome in systemic lupus erythematosus: treatment with plasma exchange. Am J Kidney Dis 6:154?160","journal-title":"Am J Kidney Dis"},{"key":"CR256","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0090-1229(90)90028-O","volume":"57","author":"Y Itoh","year":"1990","unstructured":"Itoh Y, Sekine H, Honoso O, Takeuchi T, Koide J, Takano M, Abe T (1990) Thrombotic thrombocytopenic purpura in two patients with systemic lupus erythematosus: clinical significance of anti platelet antibodies. Clin Immunol Immunopathol 57: 125?136","journal-title":"Clin Immunol Immunopathol"},{"key":"CR257","first-page":"604","volume":"16","author":"ES Weiner","year":"1989","unstructured":"Weiner ES, Abeles M (1989) Aseptic necrosis and glucocorticosteroids in systemic lupus erythematosus; a reevaluation. J Rheumatol 16:604?608","journal-title":"J Rheumatol"},{"key":"CR258","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1136\/ard.48.8.672","volume":"48","author":"K Nagasawa","year":"1989","unstructured":"Nagasawa K, Ishii Y, Mayumi T, Tada T, Ueda A, Yamauchi Y, Kusaba T, Niho Y (1989) Avascular necrosis of bone in systemic lupus erythematosus: possible role of haemostatic abnormalities. Ann Rheum Dis 48:672?676","journal-title":"Ann Rheum Dis"},{"key":"CR259","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0140-6736(87)92870-4","volume":"I","author":"DT Felson","year":"1987","unstructured":"Felson DT, Anderson JJ (1987) A cross study evaluation of association between steroid dose and bolus steroids and avascular necrosis of bone. Lancet I:902?906","journal-title":"Lancet"},{"key":"CR260","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00005792-198003000-00004","volume":"59","author":"TM Zizic","year":"1980","unstructured":"Zizic TM, Hungerford DS, Stevens MB (1980) Ischemic bone necrosis in systemic lupus erythematosus. I. early diagnosis of ischemic necrosis of bone. II. The treatment of ischemic necrosis of bone in systemic lupus erythematosus. Medicine (Baltimore) 59:134?148","journal-title":"Medicine (Baltimore)"},{"key":"CR261","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0022-3476(74)80281-7","volume":"85","author":"JM Bergstein","year":"1974","unstructured":"Bergstein JM, Wiens C, Fish AJ, Vernier RL, Michael A (1974) Avascular necrosis of bone in systemic lupus erythematosus. J Pediatr 85:31?35","journal-title":"J Pediatr"},{"key":"CR262","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0002-9343(76)90431-9","volume":"60","author":"MB Urowitz","year":"1976","unstructured":"Urowitz MB, Bookman AAM, Koehler BE, Gordon DA, Smythe HA, Ogryzlo MA (1976) The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 60:221?225","journal-title":"Am J Med"},{"key":"CR263","first-page":"696","volume":"132","author":"S Ishikawa","year":"1978","unstructured":"Ishikawa S, Segar WE, Gilbert EF, Burkholder PM, Levy JM, Visekul C (1978) Myocardial infarct in a child with systemic lupus erythematosus. Am J Dis Child 132:696?699","journal-title":"Am J Dis Child"},{"key":"CR264","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0002-9343(75)90575-6","volume":"58","author":"HB Bulkley","year":"1975","unstructured":"Bulkley HB, Roberts WC (1975) The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. Am J Med 58:243?264","journal-title":"Am J Med"},{"key":"CR265","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/art.1780310706","volume":"31","author":"NT Ilowite","year":"1988","unstructured":"Ilowite NT, Samual P, Ginzler E, Jacobson MS (1988) Dyslipoproteinemia in pediatric systemic lupus erythematosus. Arthritis Rheum 31:859?863","journal-title":"Arthritis Rheum"},{"key":"CR266","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0049-0172(89)90053-X","volume":"19","author":"BE Ostrov","year":"1989","unstructured":"Ostrov BE, Min W, Eichenfeld AH, Goldsmith DP, Kaplan B, Athreya BH (1989) Hypertension in children with systemic lupus erythematosus. Semin Arthritis Rheum 19:90?98","journal-title":"Semin Arthritis Rheum"},{"key":"CR267","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0049-0172(90)90051-G","volume":"19","author":"EA Delgado","year":"1990","unstructured":"Delgado EA, Malleson PN, Pirie GE, Pretty RE (1990) The pulmonary manifestations of childhood onset systemic lupus erythematosus. Semin Arthritis Rheum 19:285?293","journal-title":"Semin Arthritis Rheum"},{"key":"CR268","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1097\/00007611-199006000-00032","volume":"83","author":"AP Pohlgeers","year":"1990","unstructured":"Pohlgeers AP, Eid NS, Shikler KN, Shearer LT (1990) Systemic lupus erythematosus: pulmonary presentation in childhood. South Med J 83:712?714","journal-title":"South Med J"},{"key":"CR269","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/art.1780170407","volume":"17","author":"JJ Canoso","year":"1974","unstructured":"Canoso JJ, Cohen AS (1974) Malignancy in a series of 70 patients with systemic lupus erythematosus. Arthritis Rheum 17: 383?390","journal-title":"Arthritis Rheum"},{"key":"CR270","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1002\/art.1780190605","volume":"19","author":"RB Lewis","year":"1976","unstructured":"Lewis RB, Castor CW, Knisley RE, Bole GG (1976) Frequency of neoplasia in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 19:1256?1260","journal-title":"Arthritis Rheum"},{"key":"CR271","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/jama.1974.03230270041025","volume":"228","author":"TJ Carlow","year":"1974","unstructured":"Carlow TJ, Glaser JS (1974) Pseudotumor cerebri syndrome in systemic lupus erythematosus. JAMA 228:197?200","journal-title":"JAMA"},{"key":"CR272","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0002-9343(76)90327-2","volume":"61","author":"A Askari","year":"1976","unstructured":"Askari A, Vignos PJ, Moskowitz RW (1976) Steroid myopathy in connective tissue diseases. Am J Med 61:485?492","journal-title":"Am J Med"},{"key":"CR273","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/00005792-198411000-00003","volume":"63","author":"RM Watson","year":"1984","unstructured":"Watson RM, Lane AT, Barnett NK, Bias WB, Arnett FC, Provost TT (1984) Neonatal lupus erythematosus. A clinical serological and immunological study with review of the literature. Medicine (Baltimore) 63:362?378","journal-title":"Medicine (Baltimore)"},{"issue":"Suppl 1","key":"CR274","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/BF02205559","volume":"9","author":"PJ Maddison","year":"1990","unstructured":"Maddison PJ (1990) Anti-Ro antibodies and neonatal lupus. Clin Rheumatol 9 [Suppl 1]:116?122","journal-title":"Clin Rheumatol"},{"key":"CR275","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/anr.1780321110","volume":"32","author":"TJA Lehman","year":"1989","unstructured":"Lehman TJA, Reichlin M, Santner TJ, Silverman E, Petty RE, Spencer CH, Hawley JB (1989) Maternal antibodies to Ro (SS-A) are associated with both early onset of disease and male sex among children with systemic lupus erythematosus. Arthritis Rheum 32:1414?1420","journal-title":"Arthritis Rheum"},{"key":"CR276","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2133.1979.tb15297.x","volume":"101","author":"R Jackson","year":"1979","unstructured":"Jackson R, Gulliver M (1979) Neonatal lupus erythematosus progressing into systemic lupus erythematosus. Br J Dermatol 101:81?86","journal-title":"Br J Dermatol"},{"key":"CR277","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM198307283090403","volume":"309","author":"JS Scott","year":"1983","unstructured":"Scott JS, Maddison PJ, Taylor PV, Esscher E, Scott O, Skinner RP (1983) Connective tissue disease, antibodies to ribonucleoprotein, and congenital heart block. N Engl J Med 309:209?212","journal-title":"N Engl J Med"},{"key":"CR278","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/BF02031963","volume":"9","author":"C Kerkhove Van","year":"1990","unstructured":"Van Kerkhove C (1990) Lupus erythematosus in childhood: effect of maternal factors beyond neonatal disease? Clin Rheumatol 9:168?170","journal-title":"Clin Rheumatol"},{"key":"CR279","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/anr.1780321111","volume":"32","author":"A Arnaiz-Virella","year":"1989","unstructured":"Arnaiz-Virella A, Vasquez-Rodriguez JJ, Vicario JL, Livilla P, Pascual D, Moreno F, Martinez-Laso J (1989) Congenital heart block immunogenetics. Evidence for an additional role of HLA class III antigens and independence of Ro antibodies. Arthritis Rheum 32:1421?1426","journal-title":"Arthritis Rheum"},{"key":"CR280","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/096120339100100104","volume":"1","author":"E Oviasu","year":"1991","unstructured":"Oviasu E, Hicks J, Cameron JS (1991) The outcome of pregnancy in women with lupus nephritis. Lupus 1:19?25","journal-title":"Lupus"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00865490.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00865490\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00865490","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T12:00:34Z","timestamp":1705492834000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00865490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,4]]},"references-count":280,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1994,4]]}},"alternative-id":["BF00865490"],"URL":"https:\/\/doi.org\/10.1007\/bf00865490","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,4]]}}}